David A. Pidduck Appointed President and CEO of Purdue Pharma (Canada)

September 25, 2017

David Pidduck

Pickering, Ontario, September 25, 2017/CNW/ — David A. Pidduck has been appointed as President and Chief Executive Officer of Purdue Pharma (Canada) with immediate effect. Since joining the company in 2014, David has been instrumental in diversifying the company’s product portfolio through alliances, partnerships and licensing agreements while also leading the organization’s commercial strategies across many therapeutic areas including pain, CNS, ophthalmology and a growing over-the-counter portfolio.

“I have every confidence that David’s energy, commitment, skills and experience will enable the team at Purdue Pharma (Canada) to continue to do the right things for the patients we serve and further grow a sustainable, integrated business here in Canada,” said outgoing President and CEO Dr. Craig Landau.

Dr. Landau will now focus his attention on his accountability for the independently operated Purdue Pharma L.P. organization in the United States.

“I’m honoured to have been chosen to lead the passionate and committed team of professionals and scientists that make Purdue Pharma (Canada) a great place to work,” said David Pidduck. “I look forward to working with the team as we continue our efforts to develop, produce and bring to market innovative medicines and evidence-based information to support healthcare professionals and help patients and their families.”

David’s international experience spans a wide array of disciplines, including sales, marketing, finance, business development and corporate strategy with more than 25 years of leadership experience in the life sciences industry.

About Purdue Pharma (Canada) Purdue Pharma (Canada) is a research-based pharmaceutical and consumer healthcare company which has operated in Canada for over 60 years. Its 400 employees are committed to improving the health and quality of life of Canadians. The company has a broad portfolio of prescription and non-prescription medications including: prescription treatments for pain, ADHD, chemotherapy-induced nausea and vomiting (CINV), various ophthalmic conditions and OTC products. The company supports evidence-based education for the safe use of its products. Its headquarters, located in Pickering, ON, include integrated research & development, formulation and manufacturing operations. Privately held and founded by physicians, Purdue Pharma (Canada) is independently associated with the worldwide Purdue/Napp/Mundipharma network of companies. Learn more at www.purdue.ca

– END –

Media Inquiries:
Sarah L. Robertson, Director of Communications
Purdue Pharma (Canada),
media@purdue.ca